New gene editing technique switches off cells ability to repair themselves
When scientists edit DNA sometimes the cells natural repair mechanism undoes the modification, this new technique prevents that from happening and reduces the side effects of genetic modification
Cite or link to this article
Griffin, M. (2016) 'New gene editing technique switches off cells ability to repair themselves', 311 Institute, 17 December. Available at: https://www.311institute.com/new-crispr-technique-switches-off-cells-natural-repair-mechanism/ (Accessed: 1 October 2026).
CRISPR, the revolutionary gene editing tool that's also been dubbed the "Genesis Engine" because of its powerful applications, promises to radically change how diseases, from HIV and blindness to Cancer, are treated and is heralding in a new era in synthetic biology and artificial lifeforms - including designer humans and even complete artificial humans after 2036. Now, scientists at Western University in Ontario have edited the editor, adding a new engineered enzyme to CRISPR that can help prevent the target DNA from repairing itself and canceling out the new genetic changes.
With human trials of gene editing happening in a number of fields CRISPR's power comes from the ability to let scientists swap out sections of DNA, removing unwanted genes like those that might cause cancer or other diseases, and splicing in more helpful ones, but unfortunately cells have a natural ability to fight back against the "damage" to their DNA strands and in some cases they can use an in house repair system, using what's known as a "Genetic template" to undo the effects.
"The problem with CRISPR is that it will cut DNA, but then DNA-repair will take that cut and stick it back together," says David Edgell, principal investigator of the study, "that means it is regenerating the site that the CRISPR is trying to target, creating a futile cycle. The novelty of our addition is that it stops that regeneration from happening."
The addition in question is an enzyme called I-Tevl, which is combined with Cas9, the DNA cutting enzyme that gives the CRISPR-Cas9 tool its name, but where Cas9 only makes cuts in one site on the genome, the newly created "TevCas9" cuts in two places, making it much harder for the cell to repair itself.
As an added bonus, using TevCas9 appears to reduce the chances of unwanted side effects as a result of the cutting by targeting genes much more directly. This is another benefit of the new technique because sometimes when the genetic makeup of a cell is edited there are "unintended consequences" and this new technique could help stop - or at least limit those from happening.
"Because there are two cut-sites, there is less chance that these two sites occur randomly in the genome; much less chance than with just one site," says co-author, Caroline Schild-Poulter.
"This remains to be tested, but this is the hope and the expectation."
FAQ
Why does this matter?
When scientists edit DNA sometimes the cells natural repair mechanism undoes the modification, this new technique prevents that from happening and reduces the side effects of genetic modification

About the author
Matthew Griffin Founder, 311 Institute
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."
Read full bio
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.
An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.
As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.
Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.
What future do you need to see?
Choose one to get started on biotech and enhanced humans and the future of your organisation.
Sources and further reading
- Western University uwo.ca
Source: first published by the 311 Institute on 17 December 2016. Cite as: Griffin, M. (2016). New gene editing technique switches off cells ability to repair themselves. 311 Institute. https://www.311institute.com/new-crispr-technique-switches-off-cells-natural-repair-mechanism/
You are welcome to quote this article with credit and a link to the original.